You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 235 No. 14, April 5, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  COMMENTARY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Humoral and Genetic Factors in Thyrotoxic Graves Disease and Neonatal Thyrotoxicosis

William L. Green, MD

JAMA. 1976;235(14):1449-1450.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WHY IS the thyroid gland hyperactive in Graves disease? Since the demise of the theory that postulated excessive pituitary thyroid-stimulating hormone secretion, most hypotheses have included some type of stimulation by immunoglobulins or activated lymphocytes, with or without a role for an intrinsic abnormality of the thyroid gland.

The presence of autoimmune phenomena in Graves disease is beyond dispute.1 Many patients have demonstrable antibodies to thyroid antigens, and Graves disease has a proved familial association with the archetypal autoimmune endocrine disease, Hashimoto thyroiditis. Graves disease is unique among so-called autoimmune diseases, however, in that an immunoglobulin that has biological effects similar to those of an important hormone, thyrotrophin, is frequently present.

Since the original observation that Graves sera can produce a prolonged stimulation of thyroid secretion in guinea pigs and mice, this "long-acting thyroid stimulator," or LATS, has been the object of intensive study. It is an immunoglobulin of . . . [Full Text PDF of this Article]


Author Affiliations

Seattle

From the Department of Medicine, University of Washington School of Medicine, Seattle.


Footnotes

Reprint requests to Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104 (Dr Green).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.